Meningococcal Vaccine Market Size, Share, By Vaccine Type (Conjugative, Polysaccharide, and Others), Serotype (Serotype A, Serotype B, Serotype C, Serotype W, and Serotype Y), Age Group (Infants, Children and Adults), Distribution Channel (Hospital Pharma
Description
Meningococcal Vaccine Market Size, Share, By Vaccine Type (Conjugative, Polysaccharide, and Others), Serotype (Serotype A, Serotype B, Serotype C, Serotype W, and Serotype Y), Age Group (Infants, Children and Adults), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Healthcare Institutions, and Others) and Region - Trends, Analysis, and Forecast till 2035
The Meningococcal Vaccine Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Meningococcal vaccine market guards against the pathogenic agent Neisseria meningitides, which can cause meningitis and septicemia, among other serious illnesses. Meningococcal conjugate vaccines (MenACWY), which offer protection against serotypes A, C, W, and Y, and Meningococcal B vaccine (MenB), which offers protection against serotype B, are the two main types of meningococcal vaccinate.
Report Highlights:
Meningococcal vaccine market size is accounted for USD 3.5 Billion in 2025.
The size is anticipated to expand at a rate of USD 6.1 Billion by 2035, and increasing at a CAGR of 6.3%.
Based on vaccine type, conjugative vaccines segment dominates in meningococcal vaccine market.
On the basis of vaccine type, serotype b segment holds the major share in meningococcal vaccine market.
Under age group, the meningococcal vaccine market is dominated by children and adults segment.
By distribution channel, hospital pharmacies is the leading segment in adhesion market.
North America is the dominating region in meningococcal vaccine market.
The Asia Pacific is expected as fastest growing segment in market.
Key Highlights
In April 2024, The World Health Organization introduced new meningococcal vaccine, known as Men5CV, for the public health in Africa, particularly in Nigeria. Men5CV provide protection against five strains of the Neisseria meningitides bacteria, of A, C, W, Y, and X. Men5CV represented as effective against meningitis diseases by offered protection against five most prevalent strain of meningococcal bacteria.
Report Analysis:
Risk Associated with Meningococcal ACWY Vaccination:
By Vaccine Type:
Canada
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
Mexico
Argentina
Rest of Latin America
Israel
South Africa
Rest of Middle East & Africa
The report also includes a competitive analysis with a detailed SWOT review, examining the strengths, weaknesses, opportunities, and threats of each leading company, as well as their market share and product offerings.
Meningococcal Vaccine Market Companies:
BIO-MED
GSK plc.
Pfizer Inc.
Sanofi
Merck & Co., Inc.
Novartis AG
CSL
Johnson & Johnson Services, Inc.
Bharat Biotech
Serum Institute of India Pvt. Ltd.
SINOVAC
Biological E Limited
Zhi Fei Biological
Beijing Tiantan Biological Products Co., Ltd.
Walvax Biotechnology Co., Ltd.
DCVMN International
What Our Report Delivers:
Key Questions Answered in the Report.
1. What was the Meningococcal Vaccine Market size in 2025?
2. What is projected growth rate of the Meningococcal Vaccine Market during 2025-2035?
3. What are the key factors driving the Meningococcal Vaccine Market growth?
4. What are leading players in the Meningococcal Vaccine Market ?
5. What are the key regions analyzed in the Meningococcal Vaccine Market ?
6. Which region is dominating in the Meningococcal Vaccine Market ?
The Meningococcal Vaccine Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Meningococcal vaccine market guards against the pathogenic agent Neisseria meningitides, which can cause meningitis and septicemia, among other serious illnesses. Meningococcal conjugate vaccines (MenACWY), which offer protection against serotypes A, C, W, and Y, and Meningococcal B vaccine (MenB), which offers protection against serotype B, are the two main types of meningococcal vaccinate.
Report Highlights:
Meningococcal vaccine market size is accounted for USD 3.5 Billion in 2025.
The size is anticipated to expand at a rate of USD 6.1 Billion by 2035, and increasing at a CAGR of 6.3%.
Based on vaccine type, conjugative vaccines segment dominates in meningococcal vaccine market.
On the basis of vaccine type, serotype b segment holds the major share in meningococcal vaccine market.
Under age group, the meningococcal vaccine market is dominated by children and adults segment.
By distribution channel, hospital pharmacies is the leading segment in adhesion market.
North America is the dominating region in meningococcal vaccine market.
The Asia Pacific is expected as fastest growing segment in market.
Key Highlights
In April 2024, The World Health Organization introduced new meningococcal vaccine, known as Men5CV, for the public health in Africa, particularly in Nigeria. Men5CV provide protection against five strains of the Neisseria meningitides bacteria, of A, C, W, Y, and X. Men5CV represented as effective against meningitis diseases by offered protection against five most prevalent strain of meningococcal bacteria.
Report Analysis:
Risk Associated with Meningococcal ACWY Vaccination:
- The risks associated with meningococcal ACWY vaccination are generally mild and temporary, but as with any medical procedure, some side effects can occur. The most common reactions include redness or soreness at the injection site, which typically resolves on its own. A small percentage of individuals may also experience muscle pain, headache, or fatigue after receiving the vaccine. Also, fainting can occur after vaccination medical procedures, often due to anxiety or pain, thus it’s important to inform a healthcare provider immediately if patient feel lightheaded, have blurred vision, or notice ringing in the ears.
- Though extremely rare, there is a remote risk of severe allergic reactions or other serious complications, including injury or even death. These rare events are monitored by the way vaccines are administered under medical supervision, with protocols in place to manage any adverse reactions promptly and effectively.
By Vaccine Type:
- Conjugative
- Polysaccharide
- Others
- Serotype A
- Serotype B
- Serotype C
- Serotype W
- Serotype Y
- Infants
- Children & Adults
- Hospital Pharmacies
- Retail Pharmacies
- Healthcare Institutions
- Others
- North America
Canada
- Europe
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
- Asia Pacific
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
- Latin America
Mexico
Argentina
Rest of Latin America
- Middle East & Africa
Israel
South Africa
Rest of Middle East & Africa
The report also includes a competitive analysis with a detailed SWOT review, examining the strengths, weaknesses, opportunities, and threats of each leading company, as well as their market share and product offerings.
Meningococcal Vaccine Market Companies:
BIO-MED
GSK plc.
Pfizer Inc.
Sanofi
Merck & Co., Inc.
Novartis AG
CSL
Johnson & Johnson Services, Inc.
Bharat Biotech
Serum Institute of India Pvt. Ltd.
SINOVAC
Biological E Limited
Zhi Fei Biological
Beijing Tiantan Biological Products Co., Ltd.
Walvax Biotechnology Co., Ltd.
DCVMN International
What Our Report Delivers:
- Regional & Country-Level Market Insights: Detailed market share analysis across key regions and countries to help you understand competitive positioning.
- Guidance for New Market Players: Actionable strategic recommendations for businesses entering the market, ensuring a strong foothold from the start.
- Comprehensive Market Forecasts: Reliable data projections for 2024, 2025, 2026, 2028, and 2032 to support long-term planning and investment decisions.
- In-Depth Market Dynamics: Analysis of drivers, restraints, opportunities, and emerging threats, along with challenges and high-potential investment areas.
- Data-Driven Business Strategies: Expert recommendations tailored to key market segments, backed by precise market evaluations.
- Competitive Intelligence: Mapping of prevailing industry trends and competitor strategies to identify growth opportunities.
- Detailed Company Profiles: In-depth analysis of major players, including their business strategies, financial performance, and recent developments.
- Supply Chain Innovations: Insights into the latest technological advancements and trends shaping supply chain efficiency.
Key Questions Answered in the Report.
1. What was the Meningococcal Vaccine Market size in 2025?
2. What is projected growth rate of the Meningococcal Vaccine Market during 2025-2035?
3. What are the key factors driving the Meningococcal Vaccine Market growth?
4. What are leading players in the Meningococcal Vaccine Market ?
5. What are the key regions analyzed in the Meningococcal Vaccine Market ?
6. Which region is dominating in the Meningococcal Vaccine Market ?
Table of Contents
192 Pages
- Meningococcal Vaccine Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Serotype
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Type Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- The National Vaccine Injury Compensation Program (VICP)
- Research & Developments
- Market Segmentation, By Vaccine Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Conjugative
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Polysaccharide
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Serotype, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Serotype A
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Serotype B
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Serotype C
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Serotype W
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Serotype Y
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Age Group, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Infants
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Children & Adults
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Distribution Channel, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Retail Pharmacies
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Healthcare Institutions
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Serotype, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Serotype, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Serotype, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Serotype, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa
- Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Serotype, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Age Group, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East and Africa
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
